Moderna has signed a memorandum of understanding (MOU) with the Kenyan government for its first mRNA vaccine manufacturing facility in Africa. The novel mRNA process uses the genetic code for the spike protein of the coronavirus and is thought to trigger a better immune response than traditional vaccines. Scientists hope the technology, which is easier…